E10A
AXP000148.1 · Viral vector gene therapy
- Platform
- adenovirus (Ad5, non-replicating, endostatin)
- Targets
- COL18A1
- Originator
- Guangzhou Doublebridge Pharmaceuticals
- Sponsor
- Guangzhou Doublebridge Pharmaceuticals
Names
| Name | Type | Source |
|---|---|---|
| E10A ambiguous | preferred name, code | curator, ncit |
| Ad-rhENDO | code | ncit |
| Adenovirus Encoding Recombinant Human Endostatin ambiguous | synonym | ncit |
Virus
- Role
- In vivo gene transfer
- Family
- Adenoviridae
- Virus
- human adenovirus 5 (NCBI Taxonomy 28285)
- Strain
- Ad5
- Replication
- non replicating
- Modifications
- non-replicating adenoviral vector encoding human endostatin
- Transgenes
- endostatin (COL18A1 fragment)
- Route
- intratumoral
- Source
- evidence
Cross-references
- NCI Thesaurus
- C61492
Approvals
No regulatory approval recorded.
Clinical trials (2)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT02630264 | E10A for the Treatment of Squamous Cell Carcinoma of the Head and Neck | Unknown | Phase 3 | 2013-06 | 2016-06 | 540 | Head and Neck Neoplasms |
| NCT00634595 | Trial of E10A in Head and Neck Cancer | Unknown | Phase 2 | 2008-03 | 2010-12 | 116 | Head and Neck Squamous Carcinoma; Nasopharyngeal Carcinoma |
Recent changes
No changes recorded in its trials yet.
Clinical papers
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 24662947 | Multicenter randomized phase 2 clinical trial of a recombinant human endostatin adenovirus in patients with advanced head and neck carcinoma. | Molecular therapy : the journal of the American Society of Gene Therapy | 2014 | cited by trial NCT00634595 |
| PMID 17426445 | A phase I clinical trial of an adenovirus-mediated endostatin gene (E10A) in patients with solid tumors. | Cancer biology & therapy | 2007 | cited by trial NCT02630264 |
Unconfirmed matches (1)
Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 18097470 | Pharmacokinetic and pharmacodynamic study of intratumoral injection of an adenovirus encoding endostatin in patients with advanced tumors. | Gene therapy | 2008 | name in abstract: E10A |
Other papers
Preclinical studies, reviews and other papers that name it.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 22116375 | E10A, an adenovirus-carrying endostatin gene, dramatically increased the tumor drug concentration of metronomic chemotherapy with low-dose cisplatin in a xenograft mouse model for head and neck squamous-cell carcinoma. | Cancer gene therapy | 2012 | name in title: E10A |
| PMID 26065034 | E10A, an adenovirus carrying human endostatin gene, in combination with docetaxel treatment inhibits prostate cancer growth and metastases. | Journal of cellular and molecular medicine | 2010 | name in title: E10A |
| PMID 17346097 | Long-Term toxicity studies in Canine of E10A, an adenoviral vector for human endostatin gene. | Human gene therapy | 2007 | name in title: E10A |
| PMID 17933553 | Bioactivity and stability analysis of endostatin purified from fermentation supernatant of 293 cells transfected with Ad/rhEndo. | Protein expression and purification | 2007 | name in title: Ad-rhENDO |
Unconfirmed matches (9)
Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 41892059 | E50A Mutation Increases the Bioluminescence Activity of picALuc. | Biosensors | 2026 | name in abstract: E10A |
| PMID 42864150 | Integrative systematics of the Neotropical doryctine wasp genus Panama (Hymenoptera: Braconidae) and related genera with the description of a new genus. | Invertebrate systematics | 2026 | name in abstract: E10A |
| PMID 27491841 | Identification of survival-promoting OSIP108 peptide variants and their internalization in human cells. | Mechanisms of ageing and development | 2017 | name in abstract: E10A |
| PMID 22234038 | Investigation on formulation and preparation of adenovirus encoding human endostatin lyophilized powders. | International journal of pharmaceutics | 2012 | name in abstract: E10A |
| PMID 22791881 | The use of quantitative real-time reverse transcriptase PCR for 5' and 3' portions of ALK transcripts to detect ALK rearrangements in lung cancers. | Clinical cancer research : an official journal of the American Association for Cancer Research | 2012 | name in abstract: E10A |
| PMID 21552418 | Identification and characterization of the alternatively spliced nuclear receptor coactivator-6 isoforms. | International journal of biological sciences | 2011 | name in abstract: E10A |
| PMID 20025664 | Deletion of dop in Mycobacterium smegmatis abolishes pupylation of protein substrates in vivo. | Molecular microbiology | 2010 | name in abstract: E10A |
| PMID 12957949 | Wide distribution of a novel pmoA-like gene copy among type II methanotrophs, and its expression in Methylocystis strain SC2. | Applied and environmental microbiology | 2003 | name in abstract: E10A |
| PMID 11967358 | Distance dependence and salt sensitivity of pairwise, coulombic interactions in a protein. | Protein science : a publication of the Protein Society | 2002 | name in abstract: E10A |
Notes
Recombinant adenovirus encoding human endostatin, developed in China and studied intratumorally in head and neck cancer with chemotherapy. Endostatin is a fragment of collagen XVIII alpha-1 (COL18A1), recorded as the gene of origin. Highest phase not verified here.
How to cite
E10A (AXP000148.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000148.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.